References
  1. Elhai M, Meune C, Boubaya M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 2017; 76:1897–1905..
  2. D’Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46(3):428-440. doi:10.1016/0002-9343(69)90044-8
  3. Jaeger VK, Wirz EG, Allanore Y, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR Study. Assassi S, editor. PLoS ONE 2016; 11:e0163894
  4. Wells AU, Hansel1 DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992; 47:738-742
  5. Wells AU. High-resolution Computed Tomography and Scleroderma Lung Disease. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v59-61. DOI: 10.1093/rheumatology/ken271.
  6. Harrison NK, Glanville AR, Strickland B, et al. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med. 1989;83(5):403-414. doi:10.1016/s0954-6111(89)80072-1
  7. Bellando-Randone S, Matucci-Cerinic M. Very early systemic sclerosis. Best Pract Res Clin Rheumatol. 2019;33(4):101428. doi:10.1016/j.berh.2019.101428
  8. Yin, Nan et al. ’Computer-aided Identification of Interstitial Lung Disease Based on Computed Tomography’. 1 Jan. 2019: 591 – 603.
  9. Mansoor A, Bagci U, Foster B, et al. Segmentation and Image Analysis of Abnormal Lungs at CT: Current Approaches, Challenges, and Future Trends. Radiographics. 2015;35(4):1056-1076. doi:10.1148/rg.2015140232
  10. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424
  11. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205
  12. Suliman YA, Dobrota R, Huscher D, et al. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Arthritis Rheumatol. 2015;67(12):3256-3261. doi:10.1002/art.39405
  13. Cohen J (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd ed. Erlbaum L Associates, Mahwah, p 703
  14. Fayers PM, Machin D (2007) Scores and measurements: validity, reliability, sensitivity. In: Quality of life: the assessment, analysis, and interpretation of patient-reported outcomes, 2nd edn. John Wiley & Sons, Chichester, pp 77–107
  15. Markstaller K, Kauczor HU, Weiler N, et al. Lung density distribution in dynamic CT correlates with oxygenation in ventilated pigs with lavage ARDS. Br J Anaesth. 2003;91(5):699–708. DOI:10.1093/bja/aeg246
  16. Weaver AL, Divertie MB, Titus JL. Pul- monary scleroderma. Dis Chest 1968; 54:490-498.
  17. Solomon JJ, Olson a. L, Fischer a., Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev 2013;22:6–19. DOI:10.1183/09059180.00005512.
  18. Jung E, Suh CH, Kim HA, Jung JY. Clinical characteristics of systemic sclerosis with interstitial lung disease. Arch Rheumatol 2018; 33: 322–27.
  19. Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990; 176: 755–759
  20. Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020;8(3):304–320. DOI:10.1016/S2213-2600(19)30480-1
  21. Gliddon AE, et al. Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis. J Rheumatol. 2011; 38:702–705.
  22. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol. 2007; 34:104–109.
  23. Varga J, Hinchcliff M. Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?. Nat Rev Rheumatol. 2014;10(4):200-202. doi:10.1038/nrrheum.2014.22
  24. Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Ann Rheum Dis. 2018 Sep; 77(9):1326-1332